• S18:E1 – Morning Commute Podcast: An AKTor and Supporting Cast Take the Stage in HR+ Breast Cancer

  • 2023/11/30
  • 再生時間: 24 分
  • ポッドキャスト

S18:E1 – Morning Commute Podcast: An AKTor and Supporting Cast Take the Stage in HR+ Breast Cancer

  • サマリー

  • In this podcast, our faculty discuss some newer treatment approaches for patients with HR-positive breast cancer including PI3K inhibition, AKT inhibition, and oral selective estrogen receptor down regulators.

    Visit www.morningcommutepodcast.com/HRPositiveBreast1 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit.

    続きを読む 一部表示
activate_samplebutton_t1

あらすじ・解説

In this podcast, our faculty discuss some newer treatment approaches for patients with HR-positive breast cancer including PI3K inhibition, AKT inhibition, and oral selective estrogen receptor down regulators.

Visit www.morningcommutepodcast.com/HRPositiveBreast1 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit.

S18:E1 – Morning Commute Podcast: An AKTor and Supporting Cast Take the Stage in HR+ Breast Cancerに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。